tetano
Editor, Senior Moderator
Sci Rep
. 2024 May 29;14(1):12365.
doi: 10.1038/s41598-024-62835-0. Kinetics of SARS-CoV-2 infection biomarkers in a household transmission study
Ana M Groh[SUP] 1 [/SUP], Maria J G T Vehreschild[SUP] 1 2 [/SUP], Damian Diaz[SUP] 1 [/SUP], Alison L Kuchta[SUP] 3 [/SUP], Christopher Dodoo[SUP] 3 [/SUP], Luis A Alvarado[SUP] 3 4 [/SUP], Neil T Parkin[SUP] 5 [/SUP], Elissa M Robbins[SUP] 3 [/SUP], Priscilla Moonsamy[SUP] 3 [/SUP], Tuna Toptan[SUP] 6 [/SUP], Sandra Ciesek[SUP] 2 6 [/SUP], Annemarie Berger[SUP] 7 [/SUP]
Affiliations
SARS-CoV-2 is the causative agent of COVID-19. Timely and accurate diagnostic testing is vital to contain the spread of infection, reduce delays in treatment and care, and inform patient management. Optimal specimen type (e.g. nasal swabs or saliva), timing of sampling, viral marker assayed (RNA or antigen), and correlation with viral infectivity and COVID-19 symptoms severity remain incompletely defined. We conducted a field study to evaluate SARS-CoV-2 viral marker kinetics starting from very early times after infection. We measured RNA and antigen levels in nasal swabs and saliva, virus outgrowth in cell culture from nasal swabs, and antibody levels in blood in a cohort of 30 households. Nine household contacts (HHC) became infected with SARS-CoV-2 during the study. Viral RNA was detected in saliva specimens approximately 1-2 days before nasal swabs in six HHC. Detection of RNA was more sensitive than of antigen, but antigen detection was better correlated with culture positivity, a proxy for contagiousness. Anti-nucleocapsid antibodies peaked one to three weeks post-infection. Viral RNA and antigen levels were higher in specimens yielding replication competent virus in cell culture. This study provides important data that can inform how to optimally interpret SARS-CoV-2 diagnostic test results.
. 2024 May 29;14(1):12365.
doi: 10.1038/s41598-024-62835-0. Kinetics of SARS-CoV-2 infection biomarkers in a household transmission study
Ana M Groh[SUP] 1 [/SUP], Maria J G T Vehreschild[SUP] 1 2 [/SUP], Damian Diaz[SUP] 1 [/SUP], Alison L Kuchta[SUP] 3 [/SUP], Christopher Dodoo[SUP] 3 [/SUP], Luis A Alvarado[SUP] 3 4 [/SUP], Neil T Parkin[SUP] 5 [/SUP], Elissa M Robbins[SUP] 3 [/SUP], Priscilla Moonsamy[SUP] 3 [/SUP], Tuna Toptan[SUP] 6 [/SUP], Sandra Ciesek[SUP] 2 6 [/SUP], Annemarie Berger[SUP] 7 [/SUP]
Affiliations
- PMID: 38811590
- DOI: 10.1038/s41598-024-62835-0
SARS-CoV-2 is the causative agent of COVID-19. Timely and accurate diagnostic testing is vital to contain the spread of infection, reduce delays in treatment and care, and inform patient management. Optimal specimen type (e.g. nasal swabs or saliva), timing of sampling, viral marker assayed (RNA or antigen), and correlation with viral infectivity and COVID-19 symptoms severity remain incompletely defined. We conducted a field study to evaluate SARS-CoV-2 viral marker kinetics starting from very early times after infection. We measured RNA and antigen levels in nasal swabs and saliva, virus outgrowth in cell culture from nasal swabs, and antibody levels in blood in a cohort of 30 households. Nine household contacts (HHC) became infected with SARS-CoV-2 during the study. Viral RNA was detected in saliva specimens approximately 1-2 days before nasal swabs in six HHC. Detection of RNA was more sensitive than of antigen, but antigen detection was better correlated with culture positivity, a proxy for contagiousness. Anti-nucleocapsid antibodies peaked one to three weeks post-infection. Viral RNA and antigen levels were higher in specimens yielding replication competent virus in cell culture. This study provides important data that can inform how to optimally interpret SARS-CoV-2 diagnostic test results.